Back to search
Teratomas
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Teratomas trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Teratomas trials you may qualify forThis phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is re…
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patient…
This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in pa…
A Non-Therapeutic Study that aims to establish a cohort of GCT survivors to understand short term and long-term adverse effects of treatment and to conduct mole…
This is a prospective, single-center, non-randomized phase II study. Patients with germ cell tumors of gonadal and extragonadal localization who have progressed…
This study aims to prospectively document the population characteristics, imaging findings, pathological features, prognostic factors, etc., of patients with me…
This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipil…
Contribute to support hypothesis of relationships between genes involve in oncogenesis and those involve in embryological development.
Sacrococcygeal teratoma (SCT) is the most common fetal and neonatal tumor. However, predicting factors of evolution, sequelae and relapse are still unreliable b…